EXCLUSIVE-PFIZER, WHICH HAS SOUGHT EMERGENCY USE AUTHORISATION FOR COVID-19 VACCINE IN INDIA, SAYS OFFICIALS NOT GIVEN ENOUGH NOTICE TO ATTEND REGULATOR'S MEETINGS
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.38 USD | -3.37% | -0.07% | -11.87% |
07:58pm | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
07:00pm | GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.87% | 149B | |
+24.17% | 562B | |
-6.25% | 358B | |
+19.20% | 322B | |
+7.57% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-6.44% | 146B | |
+2.07% | 117B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer, Which Has Sought Emergency Use Authorisation For Covid-19 Vaccine In India, Says Officials Not Given Enough Notice To Attend Regulator's Meetings